NC
RVNC

NinePointTwo Capital’s Revance Therapeutics, Inc. RVNC Stock Holding History

NinePointTwo Capital’s Portfolio RVNC Stock Details RVNC Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$329K Buy
2023
Q3 		– Sell
2023
Q2 		$213K Buy
2023
Q1 		– Sell
2022
Q4 		$217K Buy